Add like
Add dislike
Add to saved papers

[Expression of regulatory T cells and natural killer T cells in peripheral blood of children with Wilms tumor].

OBJECTIVE: To study the changes and clinical significance of CD4(+)CD25(+)CD127(low) regulatory T cells (Treg) and CD3(+)CD16(+)CD56(+) natural killer T cells (NKT) in peripheral blood of children with Wilms tumor.

METHODS: Twenty-one children with Wilms tumor were enrolled as the case group, and twenty-one healthy children for physical examinations were enrolled as the control group. Flow cytometry was used to detect the levels of CD4(+)CD25(+)CD127(low) T cells and CD3(+)CD16(+)CD56(+) T cells in peripheral blood of two groups.

RESULTS: The level of Treg cells in peripheral blood of the case group was significantly lower than in the control group (p<0.05). The level of NKT cells in peripheral blood of the case group was significantly higher than in the control group (p<0.05).

CONCLUSIONS: Treg cells and NKT cells play important roles in the occurrence and development of Wilms tumor. Treg cells and NKT cells may be useful indexes for evaluating immunological function in children with Wilms tumor.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app